We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$890M
AUM Growth
+$75M
Cap. Flow
+$15.4M
Cap. Flow %
1.72%
Top 10 Hldgs %
64.27%
Holding
143
New
7
Increased
42
Reduced
61
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 3.89%
2 Technology 1.2%
3 Consumer Discretionary 0.95%
4 Industrials 0.94%
5 Healthcare 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
101
Nike
NKE
$64.1B
$389K 0.04%
9,894
-116
-1% -$4.44K
COP icon
102
ConocoPhillips
COP
$144B
$386K 0.04%
5,461
+20
+0.4% +$1.44K
ECYT
103
DELISTED
Endocyte, Inc. Common Stock
ECYT
$382K 0.04%
35,732
ABBV icon
104
AbbVie
ABBV
$465B
$360K 0.04%
6,816
VZ icon
105
Verizon
VZ
$197B
$360K 0.04%
7,335
+120
+2% +$5.9K
V icon
106
Visa
V
$677B
$356K 0.04%
6,388
+140
+2% +$7.06K
UNP icon
107
Union Pacific
UNP
$174B
$347K 0.04%
4,132
+264
+7% +$20.9K
TGT icon
108
Target
TGT
$66.3B
$344K 0.04%
5,426
-473
-8% -$30.2K
AMGN icon
109
Amgen
AMGN
$209B
$343K 0.04%
3,001
+3
+0.1% +$341
IWS icon
110
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$329K 0.04%
5,013
BIIB icon
111
Biogen
BIIB
$30.9B
$327K 0.04%
1,170
+80
+7% +$20.7K
VBK icon
112
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
$325K 0.04%
2,660
ESRX
113
DELISTED
Express Scripts Holding Company
ESRX
$313K 0.04%
4,456
-310
-7% -$20.2K
EMC
114
DELISTED
EMC CORPORATION
EMC
$312K 0.04%
12,401
-2,240
-15% -$54.3K
VOT icon
115
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
$299K 0.03%
3,310
-690
-17% -$60.2K
EMR icon
116
Emerson Electric
EMR
$81.6B
$298K 0.03%
4,249
-94
-2% -$6.28K
NVS icon
117
Novartis
NVS
$302B
$293K 0.03%
4,073
BA icon
118
Boeing
BA
$169B
$292K 0.03%
2,139
+75
+4% +$9.75K
COST icon
119
Costco
COST
$432B
$290K 0.03%
2,444
-512
-17% -$61.2K
CVS icon
120
CVS Health
CVS
$135B
$286K 0.03%
4,000
APD icon
121
Air Products & Chemicals
APD
$65.5B
$283K 0.03%
2,748
-58
-2% -$5.85K
CL icon
122
Colgate-Palmolive
CL
$74.8B
$270K 0.03%
4,145
+72
+2% +$4.61K
STT icon
123
State Street
STT
$48.4B
$264K 0.03%
3,602
+43
+1% +$3.01K
GIS icon
124
General Mills
GIS
$20.2B
$262K 0.03%
5,259
+96
+2% +$4.78K
ABT icon
125
Abbott
ABT
$187B
$259K 0.03%
6,742

Similar funds

Ballentine Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Ballentine Partners held 143 positions worth $890M, up 9.2% from $815M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ballentine Partners's Q4 2013 filing shows 7 new, 42 increased, 61 reduced and 3 closed positions. Its largest new stake was ROCK-TENN COMPANY CL-A: 104,370 shares worth $5.48M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $9.67M.

By sector, the portfolio is most concentrated in Financials at 3.9% of assets, down from 4.1% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Ballentine Partners's largest Q4 2013 buy was ROCK-TENN COMPANY CL-A: 104,370 shares worth $5.48M.
  • Ballentine Partners added most to iShares Core MSCI Emerging Markets ETF in Q4 2013, an estimated $17.8M increase.
  • Ballentine Partners's biggest Q4 2013 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $9.67M.
  • Ballentine Partners fully exited Yum! Brands in Q4 2013, selling an estimated $284K.
  • Ballentine Partners's ten largest holdings make up 64% of its $890M portfolio in Q4 2013.
  • Ballentine Partners opened 7 new positions and closed 3 in Q4 2013.
  • Ballentine Partners's portfolio value rose 9.2% quarter-over-quarter to $890M.

Based on Ballentine Partners's 13F filing for Q4 2013, filed 6 Feb 2014.